Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Learn when mutual funds can be preferable to index funds, considering objectives, risk tolerance, and horizon. Make informed allocation decisions.
25,127 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Goldman Sachs expands its US Conviction List with four new names pegged for double-digit upside, signaling a continue...
When lululemon shares dropped after the company cut its annual forecast, it sent a clear message about the market's g...
Chinese beauty brands flock to Southeast Asia as Joy Group expands from Singapore into Malaysia, marking a strategic ...
As market nerves remain tied to crude prices, the VanEck Energy Income ETF (EINC) continues to offer a solid 3.2%-3.6...
New estimates place the true national debt per U.S. household near $1 million when counting unfunded promises. Offici...
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
A low-cost $4 treatment is gaining traction as a flesh-eating screwworm reemerges in U.S. livestock. Ranchers and vet...
New U.S. vital statistics show a continued drop in births. The trend arrives as smartphones saturate households and l...
May wholesale prices rose again for the second straight month, marking the largest back-to-back gain since 2022 and s...
Qualia unveils a Core-integrated AI suite designed to speed title and escrow workflows, including three new tools, at...
Two fresh upgrades lifted Intel shares as Jim Cramer proclaimed the company the top name in chips. The stock surged, ...